Novo Nordisk: Clinical Trials & Research Profile

Biopharma Industry (Bagsvaerd, DK / Plainsboro, NJ) · Primary Focus: Endocrinology, Obesity, and Metabolic

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Bagsvaerd, DK / Plainsboro, NJ)
Primary Therapeutic AreaEndocrinology, Obesity, and Metabolic
Active Phase II & III Studies60 active (31 recruiting now)
Total Tracked Studies (2018 to 2026)176 (130 with California sites)
Completed vs Early-Stopped Studies104 completed / 12 stopped (6.8% stop rate)
Median Closed Enrollment300 participants
FDA Drugs@FDA Original Approvals20 all-time (5 from 2018 to 2026)
Physical Hospital Site Disclosure95.3% named hospital slots

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Novo Nordisk across sibling Meru public-data platforms.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk